SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-21-000103
Filing Date
2021-01-19
Accepted
2021-01-19 17:21:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13G sc13g07422alrn_01192021.htm SC 13G 277568
2 ex991to13g07422alrn_01192021.htm EX-99.1 10448
  Complete submission text file 0000921895-21-000103.txt   289603
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 290 PLEASANT STREET UNIT 112 WATERTOWN MA 02472
Business Address 290 PLEASANT STREET UNIT 112 WATERTOWN MA 02472 617-995-0900
AILERON THERAPEUTICS INC (Subject) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90032 | Film No.: 21536386
SIC: 2834 Pharmaceutical Preparations